A review of the cardiovascular and breast actions of drospirenone in preclinical studies

@article{Simoncini2010ARO,
  title={A review of the cardiovascular and breast actions of drospirenone in preclinical studies},
  author={T. Simoncini and A. Genazzani},
  journal={Climacteric},
  year={2010},
  volume={13},
  pages={22 - 33}
}
Objective Hormone therapy is effective for the relief of menopausal symptoms. For women with a uterus, addition of a progestogen is required to protect the endometrium. However, synthetic progestins differ in certain pharmacological characteristics that may have implications for clinical practice. This literature-based review explores differences in the preclinical and clinical profiles of the progestins used in hormone therapy, focusing on their effects on the cardiovascular system and breast… Expand
Progestogen effects at vascular level: the endothelial cells
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women
Why sex matters: the biological mechanisms of cardiovascular disease
Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause.
MHT vs. veins: is there any reason to fear?
...
1
2
...

References

SHOWING 1-10 OF 80 REFERENCES
Differential effects of progestins on hemostasis.
Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
  • D. Archer
  • Medicine
  • Seminars in reproductive medicine
  • 2005
Pharmacology of different progestogens: the special case of drospirenone
  • R. Sitruk-Ware
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
Drospirenone, a progestogen with antimineralocorticoid properties: a short review
  • W. Oelkers
  • Medicine
  • Molecular and Cellular Endocrinology
  • 2004
Drospirenone in combination with estrogens: for contraception and hormone replacement therapy
  • W. Oelkers
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
Advances in hormone replacement therapy: Weight benefits of drospirenone, a 17α-spirolactone-derived progestogen
  • J. Foidart, T. Faustmann
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2007
Drospirenone and its antialdosterone properties
Effects of drospirenone on cardiovascular markers in human aortic endothelial cells
...
1
2
3
4
5
...